Saturday, February 27, 2021

February 28, 2021 at 12:11AM Janssen COVID-19 Vaccine Frequently Asked Questions

Answers to frequently asked questions about FDA's Emergency Use Authorization of the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3uz7cH3

February 28, 2021 at 12:11AM Janssen COVID-19 Vaccine

Information about the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2O5abpJ

February 28, 2021 at 12:07AM FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine

The FDA issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2NBSwGt

February 27, 2021 at 12:08AM FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting

Following a positive advisory committee meeting outcome regarding the Janssen Biotech Inc. COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3svKxcD

February 26, 2021 at 10:56PM cobas MPX

cobas MPX Test, for use on the cobas 6800/8800 Systems
Direct detection of Human Immunodeficiency Virus Type 1 (HIV-1) Group M RNA, HIV-1 Group O RNA, Human Immunodeficiency Virus Type 2 (HIV-2) RNA, Hepatitis C Virus (HCV) RNA, and Hepatitis B Virus (HBV) DNA in human plasma
Simultaneous detection and discrimination of HIV RNA, HCV RNA, and HBV DNA in human donor plasma or serum specimens

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3aUaEUK

February 26, 2021 at 06:09PM cobas Zika

This test is intended for use to screen donor samples for Zika virus RNA in plasma samples from individual human donors, including donors of whole blood and blood components, and other living donors. This test is also intended for use to screen organ and tissue donors when donor samples are obtained while the donor’s heart is still beating. Plasma from all donors should be screened as individual samples.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/37NGcJW

February 26, 2021 at 06:04PM cobas WNV

cobas® WNV is indicated for qualitative in vitro nucleic acid screening test for the direct detection of West Nile Virus (WNV) RNA in human plasma.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2GZaDim

February 26, 2021 at 06:50PM Field Science - Laboratory Manual

The Laboratory Manual is a reference manual for FDA personnel. It provides FDA personnel with information on internal procedures to be used as an agency policy for testing consumer products, training of laboratory staff, report writing, safety, research, review of private laboratory reports and cour

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2zjOZEU

February 26, 2021 at 02:43PM Biologics Rules

Proposed & Final Rules specifically related to biologics are organized by biologics product area. Cross-Center and Office of the Commissioner Proposed and Final Rules are posted in the general FDA Rules section.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/39kDGfn

February 25, 2021 at 10:19PM Coronavirus (COVID-19) Update: FDA Allows More Flexible Storage, Transportation Conditions for Pfizer-BioNTech COVID-19 Vaccine

Coronavirus (COVID-19) Update: FDA Allows More Flexible Storage, Transportation Conditions for Pfizer-BioNTech COVID-19 Vaccine

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/37NWW3M

Tuesday, February 23, 2021

February 23, 2021 at 10:08PM Coronavirus (COVID-19) Update: February 23, 2021

Coronavirus (COVID-19) Update: February 23, 2021

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3aRy11n

Monday, February 22, 2021

February 22, 2021 at 10:02PM Biological Approvals by Year

A collection of biological approval information organized by year and regulatory authorities.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/391klO2

February 22, 2021 at 08:09PM BIMO/Team Biologics/Internet Surveillance/Other

This is the main page for the CBER BIMO/Team Biologics/Internet Surveillance/Other.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2KKaoKw

February 22, 2021 at 06:13PM Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants

Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2NspWac

February 22, 2021 at 05:31PM Emergency Use Authorization for Vaccines to Prevent COVID-19

This is the Guidance for Industry for the Emergency Use Authorization for Vaccines to Prevent COVID-19. , COVID-19, Coronavirus Disease 2019, Vaccines , CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3iF3PqC

February 22, 2021 at 04:17PM COVID-19: Developing Drugs and Biological Products for Treatment or Prevention

COVID-19: Developing Drugs and Biological Products for Treatment or Prevention

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2WmLk2d

February 21, 2021 at 08:33PM Vaccine and Related Biological Product Guidances

This page contains a listing of vaccine and related biological product guidances

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Mm0pfA

Friday, February 19, 2021

February 19, 2021 at 09:15PM Evaluation and Characterization of Neutralizing Antibodies against Viruses Relevant to Blood-derived Products

A description of Pei Zhang's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ZxrodT

February 19, 2021 at 09:20PM BeneFIX

Product approval information is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia B (congenital factor IX deficiency or Christmas disease)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2uaFru5

February 19, 2021 at 08:03PM IXINITY

Indicated in adults and children ≥ 12 years of age with hemophilia B for control and prevention of bleeding episodes, and for perioperative management.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2oY9e61

February 19, 2021 at 07:38PM Biologics PREA Reviews and Labeling Changes

PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under section 505 of the Act and biological drugs licensed under section 351 of the Public Health Service Act.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Yc9luW

Thursday, February 18, 2021

February 18, 2021 at 10:58PM Developing a Toolkit to Assess Efficacy of Ebola Vaccines and Therapeutics

MCMi regulatory science project to research issues that are key to understanding and predicting if—and how—vaccines and therapeutics to prevent and treat Ebola will show efficacy

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2NzF5El

February 18, 2021 at 07:44PM Importance of Influenza Vaccination for Health Care Personnel

Importance of Influenza Vaccination for Health Care Personnel

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3s5DG9x

February 18, 2021 at 07:20PM Influenza Virus Vaccine Composition and Lot Release

Influenza Virus Vaccine Composition and Lot Release

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/38nJP8H

February 18, 2021 at 06:28PM Zostavax (Herpes Zoster Vaccine) Questions and Answers

Zostavax is an FDA licensed vaccine that helps to reduce the risk of getting herpes zoster (shingles) in individuals 50 years of age and older. Answers are provided to common questions about Zostavax and Herpes Zoster.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3awSw37

February 18, 2021 at 04:44PM Pentacel

For active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease caused by Haemophilus influenzae type b when administered to infants and children 6 weeks through 4 years of age (prior to fifth birthday).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2zRTsiA

February 18, 2021 at 04:41PM Quadracel

Indicated for active immunization against diphtheria, tetanus, pertussis and poliomyelitis. A single dose of Quadracel is approved for use in children 4 through 6 years of age as a fifth dose in the diphtheria, tetanus, pertussis vaccination (DTaP) series

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2n1IRf1

February 18, 2021 at 04:21PM Thimerosal in Vaccines Questions and Answers

Answers to commonly asked questions about Thimerosal in vaccines.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Zq29Kw

February 17, 2021 at 10:26PM Standards Development for Regenerative Medicine Therapies

Section 3036 of the 21st Century Cures Act refers to the development of standards for regenerative medicine therapies, including products designated regenerative medicine advanced therapies.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2PMDEDj

Wednesday, February 17, 2021

February 17, 2021 at 10:27PM Patient Engagement Collaborative

The Patient Engagement Collaborative (PEC) is an advancement in the FDA’s efforts to strengthen its relationship with patient communities and is being coordinated by the FDA’s Office of Patient Affairs in the Office of Clinical Policy and Programs (OCPP).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2P5qy5N

February 17, 2021 at 10:01PM ACAM2000 (Smallpox Vaccine) Questions and Answers

Questions about Smallpox and ACAM2000

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3bbYZ2E

February 17, 2021 at 06:53PM Ticks and Lyme Disease: Symptoms, Treatment, and Prevention

Lyme disease is on the rise. How can you prevent it? What are the symptoms, and what should you do if you think you or your pet have it?

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3btL9YX

February 16, 2021 at 08:58PM Emergency Use of an Investigational Drug or Biologic

Emergency Use of an Investigational Drug or Biologic - guidance

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ZpWswk

February 17, 2021 at 02:03PM Meeting Materials, Cellular, Tissue and Gene Therapies Advisory Committee

These are the Past Meeting Materials for the Cellular, Tissue and Gene Therapies Advisory Committee

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/38Wgalk

February 17, 2021 at 02:03PM 2021 Meeting Materials, Cellular, Tissue and Gene Therapies Advisory Committee

This is the main page for the CBER 2021 Meeting Materials, Cellular, Tissue and Gene Therapies Advisory Committee.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ZmaIGl

February 17, 2021 at 02:02PM Cellular, Tissue, and Gene Therapies Advisory Committee April 15, 2021 Meeting Announcement - 04/15/2021 - 04/15/2021

This is the CBER Cellular, Tissue, and Gene Therapies Advisory Committee April 15, 2021 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3dkFjMq

February 16, 2021 at 09:51PM Regulatory Submissions in Electronic Format for Biologic Products

FDA has started the transition to a more automated electronic review process for these submissions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3cljjNh

February 16, 2021 at 08:58PM Vaccine Adverse Event Reporting System (VAERS) Questions and Answers

VAERS is a national vaccine safety surveillance program created as an outgrowth of the National Childhood Vaccine Injury Act of 1986 (NCVIA) and is administered by the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/38ZdaGd

February 16, 2021 at 08:43PM Flu Vaccines

Influenza, also known as the flu, is a contagious disease that is caused by influenza viruses. Influenza viruses infect the respiratory tract (nose, throat, and lungs) in humans. The flu is different from a cold, mainly because the symptoms and complications are more severe.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3prN3yO

February 16, 2021 at 08:31PM Trumenba (Serogroup B Meningococcal Vaccine) Questions and Answers

The FDA is announcing the approval of Trumenba, the first vaccine approved in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3bdjiwl

February 16, 2021 at 07:32PM Tissue Reference Group

This update includes recommendations for FY 2015 for the Tissue Reference Group.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3s5NzUZ

February 16, 2021 at 07:27PM Human Cell & Tissue Products (HCT/P) Adverse Reaction Reporting

Human Cell & Tissue Products (HCT/P) Adverse Reaction Reporting

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3psvCy7

February 16, 2021 at 06:41PM Vaccines and Related Biological Products Advisory Committee March 5, 2021 Meeting Announcement - 03/05/2021 - 03/05/2021

This is the CBER Vaccines and Related Biological Products Advisory Committee March 5, 2021 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3jUAnPG

February 16, 2021 at 05:07PM Tissue and Tissue Product Questions and Answers

Tissue and Tissue Product Questions and Answers

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3u36GRa

February 16, 2021 at 03:29PM Roster of the Cellular, Tissue and Gene Therapies Advisory Committee

This is the Roster of the Cellular, Tissue and Gene Therapies Advisory Committee.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2O2NW3e

February 12, 2021 at 11:14PM Coronavirus (COVID-19) Update: February 12, 2021

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3pgZoFG

February 12, 2021 at 08:06PM Cord Blood Banking - Information for Consumers

Expecting a baby can be a very exciting time for soon-to-be-parents. It can also be very confusing, with many decisions to make. One choice prospective parents often face is whether to donate, bank or discard their baby's cord blood. Did you know that the Food and Drug Administration (FDA) regulates

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3rSymqb

February 12, 2021 at 04:58PM PANZYGA

Indicated for 1.) Primary humoral immunodeficiency (PI) in patients 2 years of age and older
2.) Chronic immune thrombocytopenic purpura (ITP) in adults

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3qi4LFY

February 11, 2021 at 10:36PM Recently Issued Guidance Documents

This page lists Recently Issued CBER and Cross-Center Guidance Documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2GCffLB

February 11, 2021 at 10:36PM Blood Guidances

This page contains a listing of Blood Guidances guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2lznGQ9

February 11, 2021 at 10:36PM Investigational COVID-19 Convalescent Plasma

FDA plays a critical role in protecting the United States (U.S.) from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JRD7fD

February 11, 2021 at 09:47PM FDA Voices on Medical Products

FDA Voices on Medical Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3fPjV0W

February 11, 2021 at 07:38PM Blood Products Advisory Committee July 18-19, 2018 Meeting Announcement - 07/17/2018 - 07/18/2018

This is the Meeting Announcement for the July 18-19, 2018, Blood Products Advisory Committee (BPAC) Meeting.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2DTRArJ

February 11, 2021 at 04:34PM Tissue Establishment Registration

Establishments that manufacture human cells, tissues, and cellular and tissue-based products (HCT/Ps) regulated solely under section 361 of the Public Health Service (PHS) Act are required to register with FDA pursuant to 21 CFR Part 1271. Also, provided information on when to register update regist

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LHoNsS

Wednesday, February 10, 2021

February 10, 2021 at 07:42PM Vaccines Licensed for Use in the United States

The product name and trade name of vaccines licensed for use in the United States.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/35IEpCG

February 10, 2021 at 05:42PM Health Fraud Scams

Learn how to spot health fraud and avoid it.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2UElHK2

February 10, 2021 at 02:50PM Meeting Materials, Vaccines and Related Biological Products Advisory Committee

These are the Meeting Materials for the Vaccines and Related Biological Products Advisory Committee

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2NbzINy

February 10, 2021 at 02:49PM 2021 Meeting Materials, Vaccines and Related Biological Products Advisory Committee

This is the main page for the CBER 2021 Meeting Materials, Vaccines and Related Biological Products Advisory Committee (VRBPAC).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LBJJmH

February 10, 2021 at 02:49PM Vaccines and Related Biological Products Advisory Committee February 26, 2021 Meeting Announcement - 02/26/2021 - 02/26/2021

This is the CBER Vaccines and Related Biological Products Advisory Committee February 26, 2021 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Opx1Zr

February 10, 2021 at 02:07PM Biologics Guidances

This page displays links to Biologics Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XbPMD6

Tuesday, February 9, 2021

February 09, 2021 at 09:49PM Coronavirus (COVID-19) | CBER-Regulated Biologics

This page and the associated links provide information on guidance and advice relevant to the development of therapies to treat or prevent COVID-19, and contact information for developers seeking additional information or assistance.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3cPytLJ

February 09, 2021 at 09:47PM Human Cell and Tissue Establishment Registration (HCTERS) Public Query Application

Welcome to the Human Cell and Tissue Establishment Registration (HCTERS) Public Query application. You may use this application to review Human Cell and Tissue registration information for registered, inactive, and pre-registered firms.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2MT4Txc

February 09, 2021 at 09:39PM COVID-19 Vaccine Safety Surveillance

This page describes the monitoring the safety of authorized COVID-19 vaccines through both passive and active safety surveillance systems.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3jwsGPE

Monday, February 8, 2021

February 08, 2021 at 10:59PM Afluria, Afluria Southern Hemisphere

For active immunization of persons ages 6 months of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3rEdW47

February 08, 2021 at 10:43PM Afluria Quadrivalent, Afluria Quadrivalent Southern Hemisphere

For active immunization of persons ages 6 months of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/36SjwIc

February 08, 2021 at 07:06PM Tissue Research

List of Tissue Research

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2MPRDcJ

February 08, 2021 at 06:42PM Tissue & Advanced Therapies Research

This page is about Tissue & Advanced Therapies Research

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2B4RpYX

February 08, 2021 at 05:12PM Center for Biologics Evaluation and Research Patient Engagement Program

Patient input is a critical part of CBER’s understanding of diseases and conditions. Engaging with patients and listening to their perspectives on their diseases and treatments may help the center advance patient-focused medical product development.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2QRE1NS

February 06, 2021 at 01:49AM Coronavirus (COVID-19) Update: February 5, 2021

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3twJTNq

Thursday, February 4, 2021

February 05, 2021 at 01:25AM Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine Candidate

The FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 26, 2021, to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Janssen Biotech Inc.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3pQwLR2

February 05, 2021 at 01:18AM FDA In Brief: FDA Updates Emergency Use Authorization for COVID-19 Convalescent Plasma to Reflect New Data

The FDA updates the emergency use authorization for COVID-19 convalescent plasma to reflect new analyzed data.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3aBGYdK

February 05, 2021 at 12:56AM Fluzone Quadrivalent, Fluzone High-Dose Quadrivalent, Fluzone, Intradermal Quadrivalent, Fluzone Quadrivalent Southern Hemisphere

For active immunization of persons 6 months of age and older for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2C6mlZE

February 04, 2021 at 11:37PM CBER Reports

This page contains a summary of regulatory, research, and administrative accomplishments for the last 2 fiscal years and related reports.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2OUkcnu

February 04, 2021 at 11:30PM Coronavirus (COVID-19) Update: FDA Continues Important Work to Support Medical Product Development to Address New Virus Variants

FDA Continues Important Work to Support Medical Product Development to Address New Virus Variants

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Mzmquk

February 04, 2021 at 10:20PM Rare Disease Therapy Development and Access Remain Top FDA Priorities During COVID-19

FDA’s work to advance treatments for rare diseases and helping ensure continuity of care for people with rare diseases remain top priorities during COVID-19.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2MPMf5O

February 04, 2021 at 08:36PM CPG Sec. 400.210, Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs

CPG Sec. 400.210, Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3dsGAhu

February 04, 2021 at 06:44PM Partnering with the European Union and Global Regulators on COVID-19

The FDA and the European Commission (EC) and its European Medicines Agency (EMA) are collaborating on many scientific and regulatory fronts as part of our COVID-19 response.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2CJPj1P

February 04, 2021 at 04:48PM Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays

Links to the different types of Donor Screening Assays. A table for each assay is provided with detailed information such as tradename, infectious agent, format, specimen, use, manufacturer, approval date, and STN.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32MwJh9

Wednesday, February 3, 2021

February 03, 2021 at 08:45PM Consumer Updates

Science-based health and safety information you can trust.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/31VUzHA

February 03, 2021 at 05:55PM Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments

Fraudulent products that claim to cure, treat, or prevent COVID-19 haven’t been evaluated by the FDA for safety and effectiveness and might be dangerous to you and your family.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3btZ1kZ

February 03, 2021 at 04:36PM Quick Guide to Web Resources

Quick Guide to Web Resources

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32NnAWQ

Tuesday, February 2, 2021

February 02, 2021 at 10:08PM Common Ingredients in U.S. Licensed Vaccines

Common ingredients found in vaccines that are commonly administered to healthy babies, children and adults are discussed to determine their safety and effectiveness.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/39I0iXC

February 02, 2021 at 08:47PM Patient Listening Sessions

Patient Listening Sessions led by FDA’s Office of Patient Affairs provide an opportunity for medical product Centers to engage with patients, caregivers, and their advocates about their experience with a disease or condition.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2zaKMQU

February 02, 2021 at 03:25PM Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2021

This is the list of guidance topics CBER is considering for development during Calendar Year 2021.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2YE2vwQ

Monday, February 1, 2021

February 01, 2021 at 09:17PM Testing for Biotin Interference in In Vitro Diagnostic Devices

Testing for Biotin Interference in In Vitro Diagnostic Devices, Guidance for Industry, Final, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2tS7kqC

February 01, 2021 at 03:19PM Antimicrobial Resistance Information from FDA

Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32B6bAj